Insulin Makers Ask 2nd Circ. To Rethink Collusion Claims
By Matthew Perlman · September 11, 2025, 8:14 PM EDT
Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP are asking for a rehearing after a Second Circuit panel revived a proposed class action from safety-net hospitals and...
To view the full article, register now.